Sudeep Pharma Limited (BOM:544619)
India flag India · Delayed Price · Currency is INR
1,217.75
+48.85 (4.18%)
At close: Nov 17, 2026

Sudeep Pharma Revenue

Sudeep Pharma had revenue of 1.97B INR in the quarter ending September 30, 2026, with 20.92% growth. This brings the company's total for the last twelve months to 7.10B, up 26.57% year-over-year. In the fiscal year ending March 31, 2026, Sudeep Pharma had annual revenue of 6.42B with 27.94% growth.

Revenue (ttm)
7.10B
Revenue Growth
+26.57%
P/S Ratio
19.38
Revenue / Employee
13.52M
Employees
525
Market Cap
137.51B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Pharmaceutical, Food and Nutrition 3.63B 56.5%
  • Specialty Ingredients 2.80B 43.5%

By Geography

Chart
  • Others 2.93B 45.7%
  • India 2.57B 40.0%
  • United States of America 918.87M 14.3%
Fiscal year ended Mar 31, 2026 See the full Sudeep Pharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20266.42B1.40B27.94%
Mar 31, 20255.02B427.19M9.30%
Mar 31, 20244.59B305.42M7.12%
Mar 31, 20234.29B841.21M24.41%
Mar 31, 20223.45B3.38B4,999.06%
Mar 31, 2004 Pro Pro Pro
Mar 31, 2003 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Sudeep Pharma News

More News